Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
21,755,078
-
Shares change
-
+21,755,078
-
Total reported value, excl. options
-
$550,829,286
-
Value change
-
+$550,829,286
-
Number of buys
-
58
-
Price
-
$25.32
Significant Holders of AIMMUNE THERAPEUTICS INC - COM (AIMT) as of Q3 2015
58 filings reported holding AIMT - AIMMUNE THERAPEUTICS INC - COM as of Q3 2015.
AIMMUNE THERAPEUTICS INC - COM (AIMT) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,755,078 shares
.
Largest 10 shareholders include FMR LLC (6,087,235 shares), Foresite Capital Management II, LLC (4,087,900 shares), Aisling Capital LLC (2,820,000 shares), ADAGE CAPITAL PARTNERS GP LLC (1,241,400 shares), Partner Fund Management, L.P. (996,112 shares), Sectoral Asset Management Inc (792,638 shares), RA CAPITAL MANAGEMENT, LLC (790,200 shares), RS INVESTMENT MANAGEMENT CO LLC (715,963 shares), ALLIANCEBERNSTEIN L.P. (606,029 shares), and VANGUARD GROUP INC (562,924 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.